Atlas Venture Life Science Advisors’s Disc Medicine IRON Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $126M | Hold |
2,384,456
| – | – | 19.07% | 2 |
|
2025
Q1 | $118M | Sell |
2,384,456
-125,000
| -5% | -$6.21M | 22.69% | 2 |
|
2024
Q4 | $159M | Hold |
2,509,456
| – | – | 19.41% | 3 |
|
2024
Q3 | $123M | Hold |
2,509,456
| – | – | 11.43% | 4 |
|
2024
Q2 | $113M | Buy |
2,509,456
+222,223
| +10% | +$10M | 11.91% | 4 |
|
2024
Q1 | $142M | Sell |
2,287,233
-267,939
| -10% | -$16.7M | 13.14% | 3 |
|
2023
Q4 | $148M | Sell |
2,555,172
-190,163
| -7% | -$11M | 17.58% | 2 |
|
2023
Q3 | $129M | Sell |
2,745,335
-716,449
| -21% | -$33.7M | 19.98% | 1 |
|
2023
Q2 | $154M | Hold |
3,461,784
| – | – | 19.13% | 1 |
|
2023
Q1 | $73.4M | Hold |
3,461,784
| – | – | 9.93% | 4 |
|
2022
Q4 | $68.9M | Buy |
3,461,784
+3,286,638
| +1,877% | +$65.4M | 8.29% | 5 |
|
2022
Q3 | $8.62M | Hold |
175,146
| – | – | 0.95% | 11 |
|
2022
Q2 | $8.88M | Hold |
175,146
| – | – | 1.48% | 10 |
|
2022
Q1 | $7.3M | Hold |
175,146
| – | – | 0.92% | 13 |
|
2021
Q4 | $15.3M | Buy |
+175,146
| New | +$15.3M | 1.4% | 13 |
|